Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or North Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to North Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. North Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kendall Wannamaker (NPI 1962882886)

Field	Value
Entity Type	Individual
Organization	Kendall Wannamaker
Address	2170 Midland Rd
City	Southern Pines
State	NC
ZIP	28387
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 5, 2015

Payer Source	Total Paid
Medicare	$2.7M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-only biller: lifetime Medicare revenue is $2.7M while there is no Medicaid billing on file, so payer mix is heavily concentrated on Medicare. The provider’s NPI was enumerated on 2015-06-05 (~11 years ago), indicating roughly a decade of billing history to evaluate patterns against national peers.

Revenue is highly concentrated in intravitreal drug administrations: the precomputed top three Medicare codes account for 77.9% of this provider’s total Medicare revenue, driven by J0178 (35.3%), J2777 (28.7%), and J2778 (14.0%). This concentration signals clinical and business dependence on anti-VEGF and related retinal drug therapies for the bulk of revenue.

The code mix and descriptions point to a retina-focused ophthalmology practice that delivers frequent intravitreal injections and diagnostic retinal imaging. High-volume drug codes (J0178, J2777, J2778) plus a very large count for retinal imaging code 92134 indicate ongoing office-based medical retina management (AMD, DME, other retinal vascular disease), with smaller contributions from surgical codes such as 67036 and 67108.

On competitive standing for the top drug codes, this provider is a modest-to-solid participant rather than an outlier: J0178 ranks #931 of 3204 providers (71th percentile; typical, unremarkable volume for this code), J2777 ranks #357 of 2039 (82th percentile; typical, unremarkable volume for this code), and J2778 ranks #208 of 1208 (83th percentile; typical, unremarkable volume for this code). Those percentiles suggest routine, market-typical utilization of these agents rather than market leadership.

Retinal imaging is an exception to the otherwise typical national standing: 92134 shows 2.4K claims and $71.4K revenue (2.7% of Medicare revenue) and ranks #731 of 26868 providers (97th percentile; extreme outlier, far above typical national volume for this code). This extreme relative imaging volume supports a high-throughput monitoring workflow and reinforces the interpretation of a retina-centric outpatient operation.

Evaluation-and-management activity supports the injection/imaging mix with above-typical office follow-up volume: 99213 has 588 claims ($35.3K revenue) and ranks #20150 of 457151 providers (96th percentile; notably above typical national volume for this code), while 99214 has 324 claims ($29.2K revenue) and ranks #91663 of 479517 providers (81th percentile; typical, unremarkable volume for this code). Together these E/M volumes are consistent with frequent follow-up visits required for intravitreal therapy protocols.

The provider also uses a range of intravitreal agents and implants beyond the top three drugs, indicating therapeutic diversity in retina care: J0179 (brolucizumab) appears with 552 claims and $135.2K revenue (5.1% of Medicare revenue) and ranks #23 of 64 providers (65th percentile; typical, unremarkable volume for this code), and J7312 (dexamethasone implant) has 483 claims and $76.3K revenue (2.9% of Medicare revenue) and ranks #53 of 492 providers (89th percentile; typical, unremarkable volume for this code). These line items suggest use of both anti-VEGF biologics and sustained-release steroid implants as part of the practice’s therapeutic mix.

Surgical retina procedures (e.g., 67036 vitrectomy with 21 claims, $13.9K revenue; 67108 retinal detachment repair with 14 claims, $12.7K revenue) are present but account for a small share of revenue relative to injection and imaging services. This indicates the practice is primarily clinic-based medical retina care with limited operative throughput on Medicare patients.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,360	$690	$941.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	26,400	$30	$765.6K
J2778	Injection, ranibizumab, 0.1 mg	2,100	$180	$373.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,550	$90	$137.5K
J0179	Injection, brolucizumab-dbll, 1 mg	550	$250	$135.2K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	480	$160	$76.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,380	$30	$71.4K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	590	$60	$35.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	320	$90	$29.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	160	$110	$17.2K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. North Carolina Distribution

Kendall Wannamaker — 3 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — North Carolina

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	37	100	950	$690	$881K
J2777	17	70	12,990	$30	$503.7K
J2778	7	50	620	$180	$202.2K
J0179	2	10	550	$250	$108.2K
67028	28	120	780	$90	$80K
J7312	4	20	390	$160	$56.4K
67042	22	30	20	$990	$23.8K
67036	8	20	20	$840	$16.7K
67108	10	20	10	$960	$15.3K
99214	3,278	18,060	110	$80	$15.1K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kendall Wannamaker, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Cincinnati Physicians Company, LLC	OH	Family Medicine Physician	$0	$65.2M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
West Chester Hospital LLC	OH	General Acute Care Hospital	$0	$19.5M
Kettering Independent Medical Group Inc	OH	Orthopaedic Surgery Physician	$0	$8.4M
Arghavan Almony	NC	Ophthalmology Physician	$3.9M	$0
James Osher	OH	Ophthalmology Physician	$3.7M	$0
Bruce Buerk	OH	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
Juan Lebron	OH	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Zeina Haddad	NC	Ophthalmology Physician	$2.7M	$0
Hang Pham	OH	Ophthalmology Physician	$2.6M	$0

Nearby Providers

Other providers in the same ZIP code as Kendall Wannamaker, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sandhills Pediatrics	NC	Pediatrics Physician	$0	$32.8M
Integrated Pain Solutions PLLC	NC	Interventional Pain Medicine Physician	$0	$12.7M
Magnolia Gardens	NC	Assisted Living Facility	$0	$8.3M
The Eye Surgery Center Of The Carolinas LP	NC	Ambulatory Surgical Clinic/Center	$3.1M	$813.9K
Brooks Mays	NC	Endocrinology, Diabetes & Metabolism Physician	$569.7K	$0
John French	NC	Ophthalmology Physician	$453.7K	$0
Michol Stanzione	NC	Internal Medicine Physician	$433.8K	$0
Tarra Millender	NC	Ophthalmology Physician	$391.9K	$0
Anna Fakadej	NC	Ophthalmology Physician	$386.1K	$0
Jeffrey White	NC	Ophthalmology Physician	$385.5K	$0

Kendall Wannamaker — Billing Profile & Reimbursement Data

Sign up for Kendall Wannamaker — Billing Profile & Reimbursement Data policy alerts

Kendall Wannamaker — Billing Profile & Reimbursement Data

Sign up for Kendall Wannamaker — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References